Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Arsen, Osipov"'
Autor:
Keyu Li, Junke Wang, Rui Zhang, Jiawei Zhou, Birginia Espinoza, Nan Niu, Jianxin Wang, Noelle Jurcak, Noah Rozich, Arsen Osipov, MacKenzie Henderson, Vanessa Funes, Melissa Lyman, Alex B. Blair, Brian Herbst, Mengni He, Jialong Yuan, Diego Trafton, Chunhui Yuan, Michael Wichroski, Xubao Liu, Juan Fu, Lei Zheng
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-6 (2024)
Abstract Due to the challenge for intratumoral administration, innate agonists have not made it beyond preclinical studies for efficacy testing in most tumor types. Pancreatic ductal adenocarcinoma (PDAC) has a hostile tumor microenvironment that ren
Externí odkaz:
https://doaj.org/article/bfd08d1266be4922922c25e98fb0b353
Autor:
Stephanie N. Shishido, Emmeline Lin, Nicholas Nissen, George Courcoubetis, Divya Suresh, Jeremy Mason, Arsen Osipov, Andrew E. Hendifar, Michael Lewis, Srinivas Gaddam, Stephen Pandol, Peter Kuhn, Simon K. Lo
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-10 (2024)
Abstract Pancreatic ductal adenocarcinoma (PDAC) has a five-year survival rate of less than 10% due to its late diagnosis, rapid metastasis, and chemotherapeutic resistance. For a small proportion (10–20%) of early-stage patients however, surgical
Externí odkaz:
https://doaj.org/article/506e6fc2a6214994b7bc1407041b55d0
Autor:
Bhupinder Kaur, Yee Hui Yeo, Jeff Liang, Michael Luu, Walid Ayoub, Alexander Kuo, Hirsh Trivedi, Kamya Sankar, Jun Gong, Andrew Hendifar, Arsen Osipov, Kambiz Kosari, Nicholas Nissen, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 2, Pp 230-237 (2024)
Background and Aims: The change in hepatocellular carcinoma (HCC) care continuum during the coronavirus disease 2019 (COVID-19) pandemic remains unknown at a national level in the United States. We sought to determine the impact of the pandemic on in
Externí odkaz:
https://doaj.org/article/344988ee4f5e4b03989b5222e9cc73fc
Autor:
Kamya Sankar, Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar, Ekaterina K. Koltsova, Ju Dong Yang
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 1, Pp 1-15 (2024)
Liver cancer remains a challenge of global health, being the 4th leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and is usually precipitated by chronic viral infections (hepatit
Externí odkaz:
https://doaj.org/article/ff02d2f3ef1c487fa33fd617d82cefc5
Autor:
Eric M. Chung, MD, MS, Diana J. Lu, MD, Anthony T. Nguyen, MD, PhD, Andrew E. Hendifar, MD, Nicholas N. Nissen, MD, Jun Gong, MD, Arsen Osipov, MD, Alexandra Gangi, MD, Marc A. Attiyeh, MD, Katelyn M. Atkins, MD, PhD, Mitchell Kamrava, MD, MHDS
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 5, Pp 101471- (2024)
Purpose: The role of preoperative stereotactic body radiation therapy (SBRT) in pancreatic cancer is controversial, and questions regarding the optimal dose and radiation treatment field remain. To better inform future investigations of SBRT dose and
Externí odkaz:
https://doaj.org/article/8dea7874084f47a2b65d72a75f80e253
Autor:
Yi Jiang, Yazan Abboud, Jeff Liang, Brent Larson, Arsen Osipov, Jun Gong, Andrew E. Hendifar, Katelyn Atkins, Quin Liu, Nicholas N. Nissen, Debiao Li, Stephen J. Pandol, Simon K. Lo, Srinivas Gaddam
Publikováno v:
Cancers, Vol 16, Iss 5, p 971 (2024)
In previous studies, a significant increase in the incidence of pancreatic cancer among younger women compared to men in the United States was noted. However, the specific histopathologic characteristics were not delineated. This population-based stu
Externí odkaz:
https://doaj.org/article/31440a53eecd4c428bd7e5b18ae906de
Autor:
Jun Gong, Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Y. Ye, Julianne C. Yang, Jonathan P. Jacobs, Simon Lo, Nick Nissen, Srinivas Gaddam, Mourad Tighiouart, Arsen Osipov, Andrew Hendifar
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract In this phase I dose-escalation trial, we assess the maximum tolerated dose (MTD) of Bermekimab in combination with Nanoliposomal Irinotecan (Nal-Iri) and 5-Fluorouracil/Folinic Acid (5-FU/FA). Secondarily, we investigate effects on weight,
Externí odkaz:
https://doaj.org/article/e263745a6ab941d78e370e228fec8e54
Autor:
Tao Xia, Keyu Li, Nan Niu, Yingkuan Shao, Ding Ding, Dwayne L. Thomas, Hao Jing, Kenji Fujiwara, Haijie Hu, Arsen Osipov, Chunhui Yuan, Christopher L. Wolfgang, Elizabeth D. Thompson, Robert A. Anders, Jin He, Yiping Mou, Adrian G. Murphy, Lei Zheng
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-20 (2022)
Abstract Background Immunotherapy has demonstrated a limited clinical efficacy in approximately 5% of cholangiocarcinoma. The main challenges for an effective immunotherapy response in cholangiocarcinoma arise from the tumor microenvironment, which i
Externí odkaz:
https://doaj.org/article/0811bea100fd47df96bb43572ac97480
Autor:
Gillian Gresham, Veronica R. Placencio‐Hickok, Marie Lauzon, Tyra Nguyen, Haesoo Kim, Sejal Mehta, Shirley Paski, Stephen J. Pandol, Arsen Osipov, Jun Gong, Laith H. Jamil, Nicholas Nissen, Simon K. Lo, Andrew E. Hendifar
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 6, Pp 1959-1968 (2021)
Abstract Background Advanced pancreatic ductal adenocarcinoma (PDAC) is characterized by progressive weight loss and nutritional deterioration. This wasting has been linked to poor survival outcomes, alterations in host defenses, decreased functional
Externí odkaz:
https://doaj.org/article/c41de02b68744dcc8025ab26ceb94b9b
Autor:
Hayato Muranaka, Andrew Hendifar, Arsen Osipov, Natalie Moshayedi, Veronica Placencio-Hickok, Nicholas Tatonetti, Aleksandr Stotland, Sarah Parker, Jennifer Van Eyk, Stephen J. Pandol, Neil A. Bhowmick, Jun Gong
Publikováno v:
Cancers, Vol 15, Iss 11, p 3020 (2023)
Pancreatic cancer (PC) is one of the deadliest cancers. Developing biomarkers for chemotherapeutic response prediction is crucial for improving the dismal prognosis of advanced-PC patients (pts). To evaluate the potential of plasma metabolites as pre
Externí odkaz:
https://doaj.org/article/bb44bdcda21948919eab4a1f2217b4c6